论文部分内容阅读
急性心肌梗死后冠脉血运重建患者SCD 发生率低芬兰医学研究人员最近的一项研究表明,接受最优化治疗(冠脉血运重建、β-阻滞剂、阿斯匹林、他汀类药物和血管紧张素转换酶抑制剂)的急性心肌梗死(AMI)患者,与未接受最优化治疗者(多为老年患者、妇女,糖尿病患者和左室射血分数降低的患者)相比,SCD发生率显著减少。其中,冠脉血运重建对减少SCD的影响最大。
Low incidence of SCD in patients undergoing coronary revascularization after acute myocardial infarction A recent study by Finnish medical researchers showed that patients receiving optimal therapy (coronary revascularization, beta-blockers, aspirin, statins And angiotensin-converting enzyme inhibitors) in patients with acute myocardial infarction (AMI) compared with those who did not receive the most optimized treatment (mostly elderly patients, women, patients with diabetes and patients with decreased left ventricular ejection fraction), SCD occurred The rate is significantly reduced. Among them, coronary revascularization has the greatest impact on reducing SCD.